Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Turku
With
Sanofi
Turku University Hospital
Vaasa Central Hospital, Vaasa, Finland
medbase Oy Ltd
Age
18–60
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subjects may be included in the study only if they meet all of the following criteria:
1. The patient has received information on the purpose of the study and the meaning of the treatment, and has given verbal and written consent to participate in the study. The patient is accessible for treatment and follow-up.
2. Histologically verified diagnosis of breast cancer
3. High risk for recurrence ( node positive or node negative if T2 with histological grade 2 or 3, or Pgr negative)
4. No metastases
5. Females, age =\<60
6. No concomitant regular medication which is either substrate, inducer or inhibitor of CYP3A4
You may not be if
Subjects will be excluded from the study for any of the following reasons:
1. Poor performance status,\>=2 according to WHO
2. Inadequate bone marrow reserve defined as:
* hemoglobin \< 100 g/L
* leukocytes \< 3.0 x 10E9/L or neutrophiles \< 1.5 x 10E9/L
